Subscribe to RSS

DOI: 10.1055/s-0044-1791694
FDG-PET/CT Avid Uptake of a Biopsy-Proven Aggressive Melanotic Schwannoma of the S2 Spinal Nerve Root

Abstract
Malignant melanotic nerve sheath tumors (MMNSTs), also known as a melanocytic schwannoma (MS), are a rare type of peripheral nerve sheath tumors including Schwann cells with melanocytic differentiation. Only a few cases of spinal MMNST have been reported in literature. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) could be used to detect these lesions. A 70-year-old man with a 6-month history of backache was admitted to our hospital. PET/CT showed a paravertebral soft tissue mass along the spinal nerve at the S2 level with strong FDG uptake, and a nodule with increased FDG uptake in the right lobe of the left liver. A CT-guided biopsy of the S2 lesion was performed. The final diagnosis was spinal MS with hepatic metastasis. The patient received stereotactic body radiation therapy. Herein, we report the PET/CT findings of a case of MS with hepatic metastasis. FDG-PET/CT is helpful in the differential diagnosis of benign and malignant lesions although nonspecific.
Authors' Contributions
M.A. contributed to designing the idea and manuscript writing, O.A. contributed to the images preparation and the final review, and H.M. contributed to the literature review, table preparation, and article editing.
Ethical Approval
The research/study was approved by the Institutional Review Board at Cairo University Hospital, number CU1335, and dated January 10, 2024.
Declaration of Patient Consent
The authors certify that they have obtained all appropriate patient consent.
Publication History
Article published online:
08 October 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol 2014; 38 (01) 94-105
- 2 Mouchaty H, Conti R, Buccoliero AM, Conti P. Intramedullary melanotic schwannoma of the conus medullaris: a case report. Spinal Cord 2008; 46 (10) 703-706
- 3 Santaguida C, Sabbagh AJ, Guiot MC, Del Maestro RF. Aggressive intramedullary melanotic schwannoma: case report. Neurosurgery 2004; 55 (06) 1430
- 4 Haleem S, Mahmoud MH, Singh Kainth G, Botchu R, Hassan MF. 18F-FDG PET/CT scan standardised uptake value (SUV) score for diagnosis, staging and monitoring malignancy in spinal melanotic schwannoma. J Surg Case Rep 2022; 2022 (12) rjac524
- 5 Lieber B, Han B, Allen J. et al. Utility of positron emission tomography in schwannomatosis. J Clin Neurosci 2016; 30: 138-140
- 6 Ahmed AR, Watanabe H, Aoki J, Shinozaki T, Takagishi K. Schwannoma of the extremities: the role of PET in preoperative planning. Eur J Nucl Med 2001; 28 (10) 1541-1551
- 7 Vallat-Decouvelaere AV, Wassef M, Lot G. et al. Spinal melanotic schwannoma: a tumour with poor prognosis. Histopathology 1999; 35 (06) 558-566
- 8 Acciarri N, Padovani R, Riccioni L. Intramedullary melanotic schwannoma. Report of a case and review of the literature. Br J Neurosurg 1999; 13 (03) 322-325
- 9 Solomou G, Dulanka Silva AH, Wong A, Pohl U, Tzerakis N. Extramedullary malignant melanotic schwannoma of the spine: case report and an up to date systematic review of the literature. Ann Med Surg (Lond) 2020; 59: 217-223
- 10 Ferner RE, Lucas JD, O'Doherty MJ. et al. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 2000; 68 (03) 353-357
- 11 Warbey VS, Ferner RE, Dunn JT, Calonje E, O'Doherty MJ. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 2009; 36 (05) 751-757
- 12 Chirindel A, Chaudhry M, Blakeley J. Wahl R. 18F-FDG PET/CT qualitative and quantitative evaluation in NF1 patients for detection of malignant transformation—comparison of early to delayed imaging with and without liver activity normalization. J Nucl Med 2015; 56 (03) 379-385
- 13 Beaulieu S, Rubin B, Djang D, Conrad E, Turcotte E, Eary JF. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. AJR Am J Roentgenol 2004; 182 (04) 971-974
- 14 Shah N, Sibtain A, Saunders MI, Townsend E, Wong WL. High FDG uptake in a schwannoma: a PET study. J Comput Assist Tomogr 2000; 24 (01) 55-56
- 15 Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109 (04) 982-988
- 16 Enzinger FM, Weiss SW. Benign Tumors of the Peripheral nerves. 3rd ed.. St. Louis, MO: Mosby; 1995
- 17 Salamon J, Veldhoen S, Apostolova I. et al. 18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. Eur Radiol 2014; 24 (02) 405-412
- 18 Salamon J, Papp L, Tóth Z. et al. Nerve sheath tumors in neurofibromatosis type 1: assessment of whole-body metabolic tumor burden using F-18-FDG PET/CT. PLoS One 2015; 10 (12) e0143305
- 19 Derlin T, Tornquist K, Münster S. et al. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Clin Nucl Med 2013; 38 (01) e19-e25
- 20 Ferner RE, Golding JF, Smith M. et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 2008; 19 (02) 390-394
- 21 Martin E, Geitenbeek RTJ, Coert JH. et al. A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis. Neuro-oncol 2021; 23 (04) 557-571
- 22 Brahmi M, Thiesse P, Ranchere D. et al. Diagnostic accuracy of PET/CT-guided percutaneous biopsies for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients. PLoS One 2015; 10 (10) e0138386
- 23 Solomon RA, Handler MS, Sedelli RV, Stein BM. Intramedullary melanotic schwannoma of the cervicomedullary junction. Neurosurgery 1987; 20 (01) 36-38
- 24 Shen XZ, Wang W, Luo ZY. 18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: a case report. Medicine (Baltimore) 2021; 100 (08) e24803